SCHEMBL1762079

SCHEMBL1762079

Nc1c[nH]nc1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7755979 0.71
Hydrochloric Acid SCHEMBL8420349 0.69
SCHEMBL1662549 0.67
SCHEMBL13975634 0.67
SCHEMBL15923452 0.67
SCHEMBL31501143 0.67
SCHEMBL1036977 0.67
SCHEMBL15924313 0.67
SCHEMBL6307099 0.67
Bromide SCHEMBL2387784 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112823151-B Compounds and compositions for the treatment of diseases associated with STING activity 艾福姆德尤股份有限公司 2024-11-15 CN disclosed
US-20210236466-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY NOVARTIS PHARMA AG (CH) 2021-08-05 US disclosed
US-20210236466-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY NOVARTIS PHARMA AG (CH) 2021-08-05 US disclosed
CN-112823151-A Compounds and compositions for treating diseases associated with STING activity 艾福姆德尤股份有限公司 2021-05-18 CN disclosed
EP-3818044-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY IFM Due, Inc. (US) 2021-05-12 EP disclosed
CN-108191944-B Sesquiterpenes aspertepinol B derivative from marine microorganisms, synthetic method and carbohydrase application 华南师范大学 2020-12-11 CN disclosed
CN-108299541-B Sesquiterpenes aspertepinol B derivative from marine microorganisms, synthetic method and anti-inflammatory application 华南师范大学 2020-12-11 CN disclosed
WO-2020150417-A2 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY IFM DUE, INC. (US) 2020-07-23 WO disclosed
WO-2020150417-A2 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY IFM DUE, INC. (US) 2020-07-23 WO disclosed
CN-110526921-A A kind of compound and its preparation method and application with anti-inflammatory effect WEST CHINA HOSPITAL SICHUAN UNIV 2019-12-03 CN disclosed
US-20150111938-A1 PROCESSES FOR THE PREPARATION OF PESTICIDAL COMPOUNDS DOW AGROSCIENCES LLC 2015-04-23 US disclosed
US-8937064-B2 Pyrazolo[1,5-a]pyrimidines useful as JAK2 inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-01-20 US disclosed
CN-103917545-A BTK inhibitors MERCK SHARP & DOHME 2014-07-09 CN disclosed
CN-103619171-A Pesticidal compositions and methods related thereto DOW AGROSCIENCES LLC 2014-03-05 CN disclosed
US-20110118255-A1 PYRAZOLO[1,5-a]PYRIMIDINES USEFUL AS JAK2 INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-05-19 US disclosed
CN-101932583-A Pyrazolo [1,5-a] pyrimidines useful as jak2 inhibitors VERTEX PHARMA 2010-12-29 CN disclosed
EP-2252618-A1 PYRAZOLO [1,5-a] PYRIMIDINES USEFUL AS JAK2 INHIBITORS Vertex Pharmaceuticals Incorporated (US) 2010-11-24 EP disclosed
WO-2009085913-A1 PYRAZOLO [1,5-a] PYRIMIDINES USEFUL AS JAK2 INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-07-09 WO disclosed
US-7435831-B2 Bicyclic and bridged nitrogen heterocycles CHEMOCENTRYX, INC. (US) 2008-10-14 US disclosed
US-7435830-B2 Bicyclic and bridged nitrogen heterocycles CHEMOCENTRYX, INC. (US) 2008-10-14 US disclosed